NCT00398047 2018-09-06
Azacitidine, Darbepoetin Alfa, and Erythropoietin and Filgastrim (G-CSF) in Treating Patients With Myelodysplastic Syndromes
Wake Forest University Health Sciences
Phase 2 Terminated
Clinical Trials
1 trialsMyelodysplastic Syndromes × Hematopoietic Cell Growth Factors × Other hematologic neoplasm × Clear all